Invention Grant
- Patent Title: Quinazolinone antibiotics
-
Application No.: US14773603Application Date: 2014-03-05
-
Publication No.: US09776975B2Publication Date: 2017-10-03
- Inventor: Mayland Chang , Shahriar Mobashery , Renee Bouley
- Applicant: University of Notre Dame Du Lac
- Applicant Address: US IN Notre Dame
- Assignee: University of Notre Dame du Lac
- Current Assignee: University of Notre Dame du Lac
- Current Assignee Address: US IN Notre Dame
- Agency: Haukaas Fortius PLLC
- Agent Michael H. Haukaas
- International Application: PCT/US2014/020910 WO 20140305
- International Announcement: WO2014/138302 WO 20140912
- Main IPC: A61K31/517
- IPC: A61K31/517 ; C07D239/91 ; C07D401/06 ; C07D405/06 ; C07D471/04 ; A61K45/06 ; A61K31/43 ; A61K31/431 ; A61K31/545 ; A61K31/546 ; A61K31/7036 ; A61K31/7048 ; A61K31/519 ; A61K31/5377 ; C07D401/12

Abstract:
A new class of antibiotics effective against methicillin-resistant Staphylococcus aureus (MRSA) is disclosed. Compounds of this class can impair cell-wall biosynthesis by binding to both the allosteric and the catalytic domains of penicillin-binding protein (PBP) 2a. This class of antibiotics holds promise in reversing obsolescence of staphylococcal PBPs as important targets for antibiotics. Embodiments of the invention thus provide novel antibacterial compounds that target penicillin-binding proteins and/or other important cellular targets. Methods for inhibiting the growth and/or replication of bacteria using the compounds described herein are also provided. Various embodiments exhibit activity against gram positive bacteria, including drug-resistant strains of Staphylococcus aureus.
Public/Granted literature
- US20160031832A1 QUINAZOLINONE ANTIBIOTICS Public/Granted day:2016-02-04
Information query
IPC分类: